Gopal Varma1, Xiaoen Wang2, Elena Vinogradov3, Rupal S Bhatt4, Vikas P Sukhatme4, Pankaj Seth4, Robert E Lenkinski3, David C Alsop2, Aaron K Grant2. 1. Division of MR Research, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. gvarma@bidmc.harvard.edu. 2. Division of MR Research, Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. 3. Advanced Imaging Research Center, Radiology, UT Southwestern Medical Center, Dallas, Texas, USA. 4. Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE: In balanced steady state free precession (bSSFP), the signal intensity has a well-known dependence on the off-resonance frequency, or, equivalently, the phase advance between successive radiofrequency (RF) pulses. The signal profile can be used to resolve the contributions from the spectrally separated metabolites. This work describes a method based on use of a variable RF phase advance to acquire spatial and spectral data in a time-efficient manner for hyperpolarized 13C MRI. THEORY AND METHODS: The technique relies on the frequency response from a bSSFP acquisition to acquire relatively rapid, high-resolution images that may be reconstructed to separate contributions from different metabolites. The ability to produce images from spectrally separated metabolites was demonstrated in vitro, as well as in vivo following administration of hyperpolarized 1-13C pyruvate in mice with xenograft tumors. RESULTS: In vivo images of pyruvate, alanine, pyruvate hydrate, and lactate were reconstructed from four images acquired in 2 s with an in-plane resolution of 1.25 × 1.25 mm(2) and 5 mm slice thickness. CONCLUSION: The phase advance method allowed acquisition of spectroscopically selective images with high spatial and temporal resolution. This method provides an alternative approach to hyperpolarized 13C spectroscopic MRI that can be combined with other techniques such as multiecho or fluctuating equilibrium bSSFP. Magn Reson Med 76:1102-1115, 2016.
PURPOSE: In balanced steady state free precession (bSSFP), the signal intensity has a well-known dependence on the off-resonance frequency, or, equivalently, the phase advance between successive radiofrequency (RF) pulses. The signal profile can be used to resolve the contributions from the spectrally separated metabolites. This work describes a method based on use of a variable RF phase advance to acquire spatial and spectral data in a time-efficient manner for hyperpolarized 13C MRI. THEORY AND METHODS: The technique relies on the frequency response from a bSSFP acquisition to acquire relatively rapid, high-resolution images that may be reconstructed to separate contributions from different metabolites. The ability to produce images from spectrally separated metabolites was demonstrated in vitro, as well as in vivo following administration of hyperpolarized 1-13C pyruvate in mice with xenograft tumors. RESULTS: In vivo images of pyruvate, alanine, pyruvate hydrate, and lactate were reconstructed from four images acquired in 2 s with an in-plane resolution of 1.25 × 1.25 mm(2) and 5 mm slice thickness. CONCLUSION: The phase advance method allowed acquisition of spectroscopically selective images with high spatial and temporal resolution. This method provides an alternative approach to hyperpolarized 13C spectroscopic MRI that can be combined with other techniques such as multiecho or fluctuating equilibrium bSSFP. Magn Reson Med 76:1102-1115, 2016.
Authors: Klaes Golman; J Stefan Petersson; Peter Magnusson; Edvin Johansson; Per Akeson; Chun-Ming Chai; Georg Hansson; Sven Månsson Journal: Magn Reson Med Date: 2008-05 Impact factor: 4.668
Authors: Sam E Day; Mikko I Kettunen; Ferdia A Gallagher; De-En Hu; Mathilde Lerche; Jan Wolber; Klaes Golman; Jan Henrik Ardenkjaer-Larsen; Kevin M Brindle Journal: Nat Med Date: 2007-10-28 Impact factor: 53.440
Authors: S J Kohler; Y Yen; J Wolber; A P Chen; M J Albers; R Bok; V Zhang; J Tropp; S Nelson; D B Vigneron; J Kurhanewicz; R E Hurd Journal: Magn Reson Med Date: 2007-07 Impact factor: 3.737
Authors: Deborah K Hill; Matthew R Orton; Erika Mariotti; Jessica K R Boult; Rafal Panek; Maysam Jafar; Harold G Parkes; Yann Jamin; Maria Falck Miniotis; Nada M S Al-Saffar; Mounia Beloueche-Babari; Simon P Robinson; Martin O Leach; Yuen-Li Chung; Thomas R Eykyn Journal: PLoS One Date: 2013-09-04 Impact factor: 3.240
Authors: Hong Shang; Subramaniam Sukumar; Cornelius von Morze; Robert A Bok; Irene Marco-Rius; Adam Kerr; Galen D Reed; Eugene Milshteyn; Michael A Ohliger; John Kurhanewicz; Peder E Z Larson; John M Pauly; Daniel B Vigneron Journal: Magn Reson Med Date: 2016-10-21 Impact factor: 4.668
Authors: Shadi A Esfahani; Cody Callahan; Nicholas J Rotile; Pedram Heidari; Umar Mahmood; Peter D Caravan; Aaron K Grant; Yi-Fen Yen Journal: Mol Imaging Biol Date: 2022-04-25 Impact factor: 3.484
Authors: Eugene Milshteyn; Cornelius von Morze; Jeremy W Gordon; Zihan Zhu; Peder E Z Larson; Daniel B Vigneron Journal: Magn Reson Med Date: 2018-02-16 Impact factor: 4.668
Authors: Hai Hu; Ashish Juvekar; Costas A Lyssiotis; Evan C Lien; John G Albeck; Doogie Oh; Gopal Varma; Yin Pun Hung; Soumya Ullas; Josh Lauring; Pankaj Seth; Mark R Lundquist; Dean R Tolan; Aaron K Grant; Daniel J Needleman; John M Asara; Lewis C Cantley; Gerburg M Wulf Journal: Cell Date: 2016-01-28 Impact factor: 41.582
Authors: Jeremy W Gordon; Hsin-Yu Chen; Nicholas Dwork; Shuyu Tang; Peder E Z Larson Journal: J Magn Reson Imaging Date: 2020-02-10 Impact factor: 5.119
Authors: Jason C Crane; Jeremy W Gordon; Hsin-Yu Chen; Adam W Autry; Yan Li; Marram P Olson; John Kurhanewicz; Daniel B Vigneron; Peder E Z Larson; Duan Xu Journal: NMR Biomed Date: 2020-03-19 Impact factor: 4.044